C型肝炎治療薬の世界市場2021年-2025年

◆英語タイトル:Global Hepatitis C Drugs Market 2021-2025
◆商品コード:IRTNTR46518
◆発行会社(リサーチ会社):Technavio
◆発行日:2021年1月11日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア太平洋、その他
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥342,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

テクナビオ社の本調査レポートでは、世界のC型肝炎治療薬市場について調査し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別(併用治療、単剤治療)分析、顧客状況、地域別状況、企業状況、企業分析などを掲載しております。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界のC型肝炎治療薬市場規模:製品別(併用治療、単剤治療)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Hepatitis C Drugs Market 2021-2025
Technavio has been monitoring the hepatitis C drugs market and it is poised to grow by $ 252.89 mn during 2021-2025 progressing at a CAGR of 1% during the forecast period. Our report on hepatitis C drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing demand for direct-acting antivirals and rising number of patient support initiatives. In addition, increasing demand for direct-acting antivirals is anticipated to boost the growth of the market as well.
The hepatitis C drugs market analysis includes product segments and geographical landscapes.

Technavio’s hepatitis C drugs market is segmented as below:
By Product
• Combination therapy
• Monotherapy

By Geographical Landscapes
• North America
• Europe
• Asia
• ROW

This study identifies the high prevalence of hepatitis C as one of the prime reasons driving the hepatitis C drugs market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on hepatitis C drugs market covers the following areas:
• Hepatitis C drugs market sizing
• Hepatitis C drugs market forecast
• Hepatitis C drugs market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hepatitis c drugs market vendors that include AbbVie Inc., Astellas Pharma Inc., Bristol-Myers Squibb Co., Cipla Inc., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., and Vertex Pharmaceuticals Inc. Also, the hepatitis c drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/hepatitis-c-drugs-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Market Characteristics
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Combination therapy – Market size and forecast 2020-2025
o Monotherapy – Market size and forecast 2020-2025
o Market opportunity by Product
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2020-2025
o Europe – Market size and forecast 2020-2025
o Asia – Market size and forecast 2020-2025
o ROW – Market size and forecast 2020-2025
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Competitive scenario
o Vendor landscape
o Landscape disruption
o Industry risks
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o AbbVie Inc.
o Astellas Pharma Inc.
o Bristol-Myers Squibb Co.
o Cipla Inc.
o F. Hoffmann-La Roche Ltd.
o Gilead Sciences Inc.
o GlaxoSmithKline Plc
o Johnson & Johnson
o Merck & Co. Inc.
o Vertex Pharmaceuticals Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2020 – 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 – 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2020
• 21: Product – Market share 2020-2025 (%)
• 22: Comparison by Product
• 23: Combination therapy – Market size and forecast 2020-2025 ($ million)
• 24: Combination therapy – Year-over-year growth 2020-2025 (%)
• 25: Monotherapy – Market size and forecast 2020-2025 ($ million)
• 26: Monotherapy – Year-over-year growth 2020-2025 (%)
• 27: Market opportunity by Product
• 28: Customer landscape
• 29: Market share by geography 2020-2025 (%)
• 30: Geographic comparison
• 31: North America – Market size and forecast 2020-2025 ($ million)
• 32: North America – Year-over-year growth 2020-2025 (%)
• 33: Europe – Market size and forecast 2020-2025 ($ million)
• 34: Europe – Year-over-year growth 2020-2025 (%)
• 35: Asia – Market size and forecast 2020-2025 ($ million)
• 36: Asia – Year-over-year growth 2020-2025 (%)
• 37: ROW – Market size and forecast 2020-2025 ($ million)
• 38: ROW – Year-over-year growth 2020-2025 (%)
• 39: Key leading countries
• 40: Market opportunity by geography ($ million)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: AbbVie Inc. – Overview
• 48: AbbVie Inc. – Business segments
• 49: AbbVie Inc. – Key offerings
• 50: AbbVie Inc. – Key customers
• 51: AbbVie Inc. – Segment focus
• 52: Astellas Pharma Inc. – Overview
• 53: Astellas Pharma Inc. – Business segments
• 54: Astellas Pharma Inc. – Key offerings
• 55: Astellas Pharma Inc. – Key customers
• 56: Astellas Pharma Inc. – Segment focus
• 57: Bristol-Myers Squibb Co. – Overview
• 58: Bristol-Myers Squibb Co. – Business segments
• 59: Bristol-Myers Squibb Co. – Key offerings
• 60: Bristol-Myers Squibb Co. – Key customers
• 61: Bristol-Myers Squibb Co. – Segment focus
• 62: Cipla Inc. – Overview
• 63: Cipla Inc. – Business segments
• 64: Cipla Inc. – Key offerings
• 65: Cipla Inc. – Key customers
• 66: Cipla Inc. – Segment focus
• 67: F. Hoffmann-La Roche Ltd. – Overview
• 68: F. Hoffmann-La Roche Ltd. – Business segments
• 69: F. Hoffmann-La Roche Ltd. – Key offerings
• 70: F. Hoffmann-La Roche Ltd. – Key customers
• 71: F. Hoffmann-La Roche Ltd. – Segment focus
• 72: Gilead Sciences Inc. – Overview
• 73: Gilead Sciences Inc. – Business segments
• 74: Gilead Sciences Inc. – Key offerings
• 75: Gilead Sciences Inc. – Key customers
• 76: Gilead Sciences Inc. – Segment focus
• 77: GlaxoSmithKline Plc – Overview
• 78: GlaxoSmithKline Plc – Business segments
• 79: GlaxoSmithKline Plc – Key offerings
• 80: GlaxoSmithKline Plc – Key customers
• 81: GlaxoSmithKline Plc – Segment focus
• 82: Johnson & Johnson – Overview
• 83: Johnson & Johnson – Business segments
• 84: Johnson & Johnson – Key offerings
• 85: Johnson & Johnson – Key customers
• 86: Johnson & Johnson – Segment focus
• 87: Merck & Co. Inc. – Overview
• 88: Merck & Co. Inc. – Business segments
• 89: Merck & Co. Inc. – Key offerings
• 90: Merck & Co. Inc. – Key customers
• 91: Merck & Co. Inc. – Segment focus
• 92: Vertex Pharmaceuticals Inc. – Overview
• 93: Vertex Pharmaceuticals Inc. – Business segments
• 94: Vertex Pharmaceuticals Inc. – Key offerings
• 95: Vertex Pharmaceuticals Inc. – Key customers
• 96: Vertex Pharmaceuticals Inc. – Segment focus
• 97: Currency conversion rates for US$
• 98: Research Methodology
• 99: Validation techniques employed for market sizing
• 100: Information sources
• 101: List of abbreviations



【掲載企業】

AbbVie Inc., Astellas Pharma Inc., Bristol-Myers Squibb Co., Cipla Inc., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Vertex Pharmaceuticals Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[C型肝炎治療薬の世界市場2021年-2025年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆